A pharmaceutical company developing drugs for autoimmune/metabolic and neurological diseases, with a special focus on the needs of individuals with Down syndrome.
Feb 23, 2021
Pharmasum Therapeutics AS announces the granting and publishing of its US patent covering composition of matter claims READ MORE >>
Jan 29, 2021
Pharmasum Therapeutics enters into the Euronext Share registry READ MORE >>
Dec 14, 2020
Dr. Reijo Salonen and Dr. Anders Fugelli elected to the Board of Directors of Pharmasum Therapeutics READ MORE >>